Keine Story von Three Rivers Pharmaceuticals mehr verpassen.

Three Rivers Pharmaceuticals

  • 24.05.2005 – 22:05

    Three Rivers Pharmaceuticals Announces Acquisition of Worldwide Rights to Amphotec(R)/Amphocil(R)

    Cranberry Township, Pennsylvania (ots/PRNewswire) - Three Rivers Pharmaceuticals, LLC announced today that it has completed the acquisition of worldwide ownership of Amphotec(R)/Amphocil(R) (amphotericin B cholesteryl sulfate complex for injection) from InterMune, Inc. (Nasdaq: ITMN). Amphotec is indicated for the treatment of invasive aspergillosis, a fungal ...